Drreddys Laboratories | RDY - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
ANI Pharmaceuticals USD 217.93M 287.88M 2025-12
Aurora Cannabis CAD 129.98M 16.05M 2025-12
Bayer EUR 10.33B 126M 2025-12
Canopy Growth CAD 87.2M 6.22M 2025-12
Cipla INR 60.98B 1.06B 2025-12
Corcept Therapeutics USD 197.64M 219K 2025-12
Drreddys Laboratories INR 72.94B 4.33B 2025-12
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Lonza CHF 2.9B 184M 2025-06
Novartis USD 9.8B 61M 2025-12
Pacira USD 193.68M 27.32M 2025-12
Phibro Animal Health USD 332.36M 20.68M 2025-12
Prestige Brands USD 200.95M 6.51M 2025-12
Richter Gedeon HUF 151.11B 20.72B 2025-09
Sun Pharmaceuticals INR 111.11B 6.97B 2025-09
Supernus Pharmaceuticals USD 197.75M 54.54M 2025-12
Teva Pharmaceutical Industries USD 4.22B 812M 2025-12